维普中文期刊产品整合服务
151篇 您的检索式:作者名="Ansley"
    题名 作者 年代 出处 被引量
1冠状动脉搭桥患者围术期血浆15-F_(2t)-isoprostane含量变化及临床意义显示文摘目的 分析常温心脏手术中血浆游离 15 F2 t isoprostane浓度变化及其与术后早期心功能的关系。方法 选择 30例在常温体外循环 (CPB)下行冠状动脉搭桥术患者 ,根据术后有 (组 )、无 (组 )应用正性肌力药物分为两组。 CPB中采用间断温血灌注 ,分别于麻醉诱导后、阻升主动脉后 30 min以及开放升主动脉后 10、30和 12 0 min抽取中心静脉血样 ,采用有高度特异性的兔血清抗体用酶标放射免疫法测量血浆中游离 15 F2 t isoprostane含量。术中至术后 6 h进行连续心排量测量。结果 15 F2 t isoprostane血浆含量于阻升主动脉后 30 m in、开放升主动脉后 10 min显著升高 ,开放升主动脉 30 m in以后开始下降。组 患者血浆 15F2 t isoprostane含量的升高呈递减趋势 ,至开放升主动脉后 30 min恢复正常 ;相反 ,术后需两种以上正性肌力药物支持以维持心脏指数 (CI) >2 .2 L· m in- 1· m- 2的患者 (组 )血浆 15 F2 t isoprostane含量至开放升主动脉后 30 m in均显著高于正常。术后 CI与开放升主动脉后 10和 30 min时血浆游离 15 F2 t isoprostane含量呈良好的负相关性 (r=- 0 .95 ,P<0 .0 1)。结论 术中 15 F2 t isoprostane血浆含量与术后心功能的恢复密切相关。黄志勇 夏正远 David M. Ansley Baljinder 2004中国危重病急救医学2004,16,3:8
2Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease显示文摘Xia Z Gu J Ansley D M 2003J Thorac Cardiovasc Surg2003,126,:1
3Tissue antioxidant capacity during anesthesia:propofol enhances in vivo red cell and tissue antioxidant capacity in a rat model显示文摘Runzer TD Ansley DM Godin DV 2002Anesth Analg2002,94,1:1
4Soil organic carbon and black carbon storage and dynamics under different fire regimes in temperate mixed-grass savanna显示文摘Ansley R J Boutton T W Skjemstad J O 2006Global Biogeochemical Cycles2006,20,3:1
5The cellular and molecular origin of reactive oxygen species generation during myocardial is- chemia and reperfusion 显示文摘Raedschelders K Ansley DM Chen DD 2012Pharmacol Ther2012,133,2:1
6The role of impulse oscillometry in detecting airway dysfunction in athletes显示文摘Price OJ Ansley L Bikov A 2015J Asthma2015,19,:1
7Base profile optimization for minimum noise figure in advanced UHV/CVD SiGe HBTs 显示文摘ANSLEY W E CRESSLER J D RICHEY D M 1994IEEE Trans Microw Theory Tech1994,46,:1
8Stem flow and porometer measurements of transpiration from honey mesquitr显示文摘ANSLEY R J DUGAS W A HEUER M L 1994J Ecp Bot1994,45,6:1
9Propofol preservation of myocardial function in patients undergoing coronary surgery using cardiopulmonary bypass is dose dependent 显示文摘Ansley DM Xia Z 2003Anesthesiology2003,98,4:1
10“Stratified and maximum information item selection procedures in com-puter adaptive testing”显示文摘Deng H T. Ansley H. Chang 0,,02:1
11Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane 显示文摘Ansley D M 2006Anesth Analg2006,103,3:1
12On the structure of moving average processes 显示文摘Ansley C F Spivey W A Wrobleski W J 1977Journal of Econometrics1977,6,:1
13High dose propofol enhances red cell antioxidant capacity during CPB in humans显示文摘Ansley DM Sun J Visser WA 1999Can J Anaesth1999,46,:1
14Oxidative stress and myocardial injury in the diabetic heart显示文摘David M Ansley Baohua Wang 2012J Pathol2012,,2:1
15The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion显示文摘Raedschelders K Ansley DM Chen DD 2012Pharmacol Ther2012,133,2:1
16Tree(Prosopis glandulosa ) effects on grass growth: An ex-perimental assessment of above-and below ground inter-actions in a temperate savanna 显示文摘Simmons M T Archer S R Ansley R J 2008Journal of Arid Envi-ronments2008,72,4:1
17Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease显示文摘Xia Z Gu J Ansley DM Xia F Yu J 2003J Thorac Cardiovasc Surg2003,126,:1
18Excess female mortality and the balance of the sexes in the population: An estimate of the number of 'missing females'显示文摘Coale Ansley J 1991Papulation and Development Review1991,17,3:1
19Lack of utility of postoperative chest radiograph in pediatric tracheotomy显示文摘PINTO J M ANSLEY J BAROODY F M 2001Otolaryngol Head Neck Surg2001,125,:1
20The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion显示文摘Koen Raedschelders David M. Ansley David D.Y. Chen 2011Pharmacology and Therapeutics2011,,2:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费